Discovery of the angiotensin converting enzyme (ACE) in the pulmonary circulation. Search for its inhibitor led to the synthesis of ACE inhibitors which are now used for the treatment of hypertension, congestive hear failure and diabetic kidney disorder.
Call Girls Jabalpur Just Call 9907093804 Top Class Call Girl Service Available
Discovery of the lung angiotensin converting enzyme 01 22 2016-pdf
1. DISCOVERY OF ANGIOTENSIN CONVERTING
ENZYME IN THE LUNG
Kevin KF Ng, MD, PhD, FRACP
Former Associate Professor of Pharmacology
University of Singapore
Former Associate Professor of Medicine
University of Miami, Florida
Presented at Department of Medicine, Tan Tock Seng Hospital, Republic of Singapore: Jan 22, 2016
2. Discovery of the lung angiotensin converting enzyme 1967
History of the renin-angiotensin system.
Vane’s blood bathed organ superfusion technique.
Estimation of half-lives in circulating blood.
Disappearance of angiotensin II in vascular beds.
Estimation of conversion of angiotensin I to angiotensin II in circulating blood.
Disappearance of angiotensin I in vascular beds
Evidence that angiotensin I is converted to angiotensin II in the lungs.
The lung as an endocrine organ.
Subsequent research on endothelium of capillaries of the pulmonary vascular bed.
Recent advances in basic science and clinical research.
16. Evidence that angiotensin I is converted to angiotensin II in lungs
1. Intravenous angiotensin I.
2. IV Exogenous Renin infusion.
3. Endogenous Renin release
from Golblatt kidney.
4. Lung perfusate from isoalated
lungs.
23. Respiratory and Non-respiratory functions of the lung
Respiratory function: Gas exchange of Carbon Dioxide for Oxygen
Non-respiratory functions: Activation, Inactivation, Free passage of vasoactive substances
Paracrine functions : Nitric oxide (NO), Prostacylcin (PGI), Platlete acting factor, Endothelin.
24. Impact of the discovery of Lung Angiotensin Converting Enzyme (ACE)
since 1967.
Unique function of the pulmonary angiotensin converting enzyme (ACE) in converting the
inactive angiotensin I to the active angiotensin II.
Selective filter of vasoactive substances in the circulation.
The endocrine function of the lung in the release of active pharmacological substances.
Development of angiotensin converting enzyme inhibitor (ACE inhibitor) in the treatment of
hypertension, congestive heart failure and diabetic kidney disease since 1981.
Recognition of the role of plasma ACE in pathological states e.g. sarcoidosis.
Recent research in ACE-2.
27. References
KKF Ng: “The dynamics of the renin-angiotensin system”.
Ph. D. Thesis, University of London, 1968.
RL Hodge, KKF Ng and JR Vane: Disappearance of angiotensin from the circulation of the dog.
Nature (1967),215,138-141.
KKF Ng and JR Vane: Conversion of angiotensin to angiotensin II.
Nature (1967), 216,762-766.
KKF Ng and Vane: Fate of angiotensin I in the circulation.
Nature (1968), 218,144-150.
KKF Ng and Vane: Some properties of angiotensin converting enzyme in the lung.
Nature (1970) 225, 1142-1144